close
Blogtrottr
兩岸國際
提供兩岸要聞、全球觀察最新訊息。 
Kindle Book Deals

We find the best deals on best-selling Kindle books for you. Just tell us which genres you love and we'll do the rest. The best part? It's completely free!
From our sponsors
安進104億美元收購Onyx
Aug 26th 2013, 12:49

生技大廠安進(Amgen)宣布,以104億美元收購生產抗癌藥的Onyx,跨足快速成長的癌症用藥市場。

兩家公司25日共同發布新聞稿說,安進同意以每股125美元收購Onyx流通在外的股票。Onyx抗血癌藥Kyprolis去年在美國核准上市,分析師預測每年可創造逾30億美元收入。Onyx目前也研究擴大用藥領域。

這項交易反映製藥業者最近捨棄大規模合併,寧鎖定擁有一到兩個深具潛力的藥品的藥廠作為併購標的。安進大部分抗癌相關產品只能支援癌症病患,而不能治療癌症本身,Onyx的治癌藥正好填補這個缺口。

安進執行長布列德威(Robert Bradway)在新聞稿中說,併購Onyx提供「增加Kyprolis價值的絕佳機會,這產品尚在開發初期,但大有前景」。

This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers. Five Filters recommends: 'You Say What You Like, Because They Like What You Say' - http://www.medialens.org/index.php/alerts/alert-archive/alerts-2013/731-you-say-what-you-like-because-they-like-what-you-say.html

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
arrow
arrow
    全站熱搜

    qmsl 發表在 痞客邦 留言(0) 人氣()